Goldman Sachs Resumes Pfizer (PFE) at Buy
Tweet Send to a Friend
Goldman Sachs resumed coverage on Pfizer (NYSE: PFE) with a Buy rating and a price target of $35.00.Analyst Jami Rubin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE